Role of [F] fludeoxyglucose positron emission tomography in the selection of liver transplantation candidates in patients with hepatocellular carcinoma.

Hepatobiliary Pancreat Dis Int

Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health; Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases, Hangzhou 310003, China.

Published: June 2017

AI Article Synopsis

  • The Milan criteria are often used to determine eligibility for liver transplantation in patients with hepatocellular carcinoma, but those with tumors beyond these criteria—if deemed non-aggressive—may still benefit from transplantation.
  • Preoperative positron emission tomography (PET) imaging was analyzed in 103 patients, revealing that positive PET findings correlated with worse tumor characteristics and higher risk of recurrence after transplantation.
  • Patients with negative PET results who exceeded the Milan criteria showed promising survival rates, indicating that PET imaging can help expand candidate selection for liver transplantation.

Article Abstract

Background: The Milan criteria are widely accepted among many centers. However, patients with hepatocellular carcinoma beyond the Milan criteria might still benefit from liver transplantation (LT) when tumor itself is not aggressive. [F] fluorodeoxyglucose positron emission tomography/computed tomography imaging could provide useful information of tumor behaviors, which is helpful to predict the prognosis for many tumors.

Method: In order to determine its role in candidate selection for LT, we therefore retrospectively analyzed 103 recipients with preoperative positron emission tomography (PET) findings.

Results: Positive PET findings (PET) were significantly associated with tumor nodule numbers (P=0.013), tumor grade (P=0.025), macro- (P=0.002) and micro-vascular invasion (P=0.002), as well as the Milan criteria (P=0.018). PET patients had significantly increased risk of tumor recurrence post-LT compared to PET negative (PET) patients (P=0.007). The 1-, 3-, and 5-year overall survival rate of PET patients were 96.0%, 87.2% and 76.2%, compared to 74.7%, 55.4% and 49.9% in PET patients, respectively (P<0.05). The 1-, 3-, and 5-year recurrence-free survival rate of PET patients were 91.8%, 81.9% and 76.0%, compared to 70.1%, 39.3% and 21.9% in PET patients, respectively (P<0.05). Recipients within the Milan criteria showed comparable 1-, 3-, and 5-year survival rates in comparison with those beyond the Milan criteria with a PET findings (1-, 3-, and 5-year overall survival rates, 97.5%, 83.3%, and 83.3% vs 90.0%, 80.0%, and 66.7%, P= 0.123; 1-, 3-, and 5-year recurrence-free survival rates, 95.1%, 73.1%, and 73.1% vs 90.0%, 78.8%, and 65.6%, P=0.148).

Conclusions: Certain patients with hepatocellular carcinoma and negative PET findings, who have exceeded the Milan criteria, are also eligible candidates for LT. Preoperative PET/CT imaging is an important marker, which should be incorporated in extended candidate selection criteria for LT.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1499-3872(17)60011-0DOI Listing

Publication Analysis

Top Keywords

pet patients
16
positron emission
12
milan criteria
12
emission tomography
8
liver transplantation
8
patients hepatocellular
8
hepatocellular carcinoma
8
pet
8
patients
6
tumor
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!